Pfizer

News

Pfizer pauses DMD gene therapy trial after boy’s death

The death of a young boy with Duchenne muscular dystrophy (DMD) who was treated with Pfizer’s experimental gene therapy in a phase 2 trial has prompted the company to paus

News

Citi analyst Andrew Baum to head Pfizer strategy team

Pfizer will draw on the expertise of Citi analyst Andrew Baum when it comes to portfolio management and capital deployment, naming him chief strategy and innovation office

News

Price cut unlocks NHS use of sickle cell drug Oxbryta

It has been nearly two years since Pfizer’s sickle cell disease (SCD) therapy Oxbryta was approved in the UK, but patients will now be able to access the treatment after a

News

Pfizer offers warranty for new haemophilia B therapy Beqvez

Pfizer has said it will launch its just-approved haemophilia B gene therapy Beqvez with a warranty programme that will provide “greater certainty” to payers, after setting

News

EU approves Pfizer antibiotic for superbug infections

Pfizer’s Emblaveo has been approved in the EU with a first-in-class indication in multidrug-resistant (MDR) infections.

News

GSK trails after Pfizer in 5-in-1 meningococcal vaccine race

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from P

Pfizer pauses DMD gene therapy trial after boy’s death

Citi analyst Andrew Baum to head Pfizer strategy team

Price cut unlocks NHS use of sickle cell drug Oxbryta

Pfizer offers warranty for new haemophilia B therapy Beqvez

EU approves Pfizer antibiotic for superbug infections

GSK trails after Pfizer in 5-in-1 meningococcal vaccine race

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Pfizer

Editor's Picks